The antitumor activity of umbelliferone in human renal cell carcinoma via regulation of the p110γ catalytic subunit of PI3Kγ

1. M. Song, Recent developments in small molecule therapies for renal cell carcinoma, Eur. J. Med. Chem.142 (2017) 383–392; https://doi.org/10.1016/j.ejmech.2017.08.00710.1016/j.ejmech.2017.08.007Search in Google Scholar

2. P. Mendiratta, B. I. Rini and M. C. Ornstein, Emerging immunotherapy in advanced renal cell carcinoma, Urol. Oncol.35 (2017) 687–693; https://doi.org/10.1016/j.urolonc.2017.08.01110.1016/j.urolonc.2017.08.011Search in Google Scholar

3. S. M. Yu, D. H. Hu and J. J. Zhang, Umbelliferone exhibits anticancer activity via the induction of apoptosis and cell cycle arrest in HepG2 hepatocellular carcinoma cells, Mol. Med. Rep.12 (2015) 3869–3873; https://doi.org/10.3892/mmr.2015.379710.3892/mmr.2015.3797Search in Google Scholar

4. D. Li, N. Wang, J. Zhang, S. Ma, Z. Zhao and E. M. Ellis, Hepatoprotective effect of 7-hydroxycou-marin against methyl glyoxal toxicity via activation of Nrf2, Chem. Biol. Interact.276 (2017) 203–209; https://doi.org/10.1016/j.cbi.2017.02.02010.1016/j.cbi.2017.02.020Search in Google Scholar

5. A. Bondev, T. Bondeva and R. Wetzker, Regulation of phosphoinositide 3-kinase γ protein kinase activity in vitro and in COS-7 cells, Signal Transduction1 (2015) 79–85.10.1002/1615-4061(200111)1:1/2<79::AID-SITA79>3.0.CO;2-0Search in Google Scholar

6. H. Guo, P. German, S. Bai, S. Barnes, W. Guo, X. Oi, H. Lou, J. Liang, E. Jonasch, G. B. Mills and Z. Ding, The PI3K/AKT Pathway and renal cell carcinoma, J. Genet. Genomics42 (2015) 343–353; https://doi.org/10.1016/j.jgg.2015.03.00310.1016/j.jgg.2015.03.003Search in Google Scholar

7. U. Maier, A. Babich and B. Nurnberg, Roles of non-catalytic subunits in gbetagamma-induced activation of class I phosphoinositide 3-kinase isoforms beta and gamma, J. Biol. Chem.274 (1999) 29311–29317.10.1074/jbc.274.41.29311Search in Google Scholar

8. M. M. Kaneda, K. S. Messer, N. Ralainirina, H. Li, C. J. Leem, S. Gorjestani, G. Woo, A. V. Nguyen, C. C. Figueiredo, P. Foubert, M. C. Schmid, M. Pink, D. G. Winkler, M. Rausch, V. J. Palombella, J. Kutok, K. McGovern, K. A. Frazer, X. Wu, M. Karin, R. Sasik, E. E. Cohen and J. A. Varner, PI3Kγ is a molecular switch that controls immune suppression, Nature539 (2016) 437–442; https://doi.org/10.1038/nature1983410.1038/nature19834Search in Google Scholar

9. M. E. Marshall, K. Kervin, C. Benefield, A. Umerani, S. Albainy-Jenei, Q. Zhao and M. B. Khazaeli, Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro, J. Cancer Res. Clin. Oncol.120 Suppl. (1994) S3-10.10.1007/BF01377114Search in Google Scholar

10. A. Vijayalakshmi and G. Sindhu, Umbelliferone arrest cell cycle at G0/G1 phase and induces apoptosis in human oral carcinoma (KB) cells possibly via oxidative DNA damage, Biomed. Pharmacotherapy92 (2017) 661–671; https://doi.org/10.1016/j.biopha.2017.05.12810.1016/j.biopha.2017.05.128Search in Google Scholar

11. J. S. Lopez-Gonzalez, H. Prado-Garcia, D. Aguilar-Cazares, J. A. Molina-Guarneros, J. Morales-Fuentes and J. J. Mandoki, Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines, Lung Cancer43 (2004) 275–283; https://doi.org/10.1016/j.lungcan.2003.09.00510.1016/j.lungcan.2003.09.005Search in Google Scholar

12. F. A. Jiménez-Orozco, J. S. López-González, A. Nieto-Rodriguez, M. A. Velasco-Velázquez, J. A. Molina-Guarneros, N. Mendoza-Patiño, M. J. García-Mondragón, P. Elizalde-Galvan, F. León-Cedeño and J. J. Mandoki, Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin, Lung Cancer34 (2001) 185–194.10.1016/S0169-5002(01)00263-XSearch in Google Scholar

13. C. M. Elinos-Baez, F. Leon and E. Santos, Effects of coumarin and 7OH-coumarin on bcl-2 and Bax expression in two human lung cancer cell lines in vitro, Cell Biol. Int.29 (2005) 703–708; https://doi.org/10.1016/j.cellbi.2005.04.00310.1016/j.cellbi.2005.04.003Search in Google Scholar

14. A. Akinleye, P. Avvaru, M. Furqan, Y. Song and D. Liu, Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics, J. Hematol. Oncol.6 (2013) 88; https://doi.org/10.1186/1756-8722-6-8810.1186/1756-8722-6-88Search in Google Scholar

15. S. Zhu, M. B. Cohen, J. D. Bjorge, J. W. Mier and D. C. Cho, PI3K inhibition potentiates Bcl-2-dependent apoptosis in renal carcinoma cells, J. Cell Mol. Med.17 (2013) 377–385; https://doi.org/10.1111/jcmm.1201910.1111/jcmm.12019Search in Google Scholar